Developing new methods to detect and treat tuberculosis
Chemical Mycobateriology
This study is working on better ways to find and treat tuberculosis (TB) using new tools and medicines, especially in places that don't have a lot of resources, so that more people can get the help they need.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10893457 on NIH RePORTER |
What this research studies
This research focuses on improving the detection and treatment of tuberculosis (TB), a disease caused by Mycobacterium tuberculosis that affects a significant portion of the global population. The project aims to create innovative detection methods suitable for low-resource settings and to identify new drugs that can effectively combat TB. By utilizing advanced techniques such as fluorescent dyes and magnetic bead-based platforms, the research seeks to enhance the accuracy and efficiency of TB diagnosis and treatment. Additionally, it will explore the role of specific lipids in the bacteria's virulence, which could lead to new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with tuberculosis or those at high risk of infection, particularly in low-resource environments.
Not a fit: Patients with non-tuberculous mycobacterial infections or those who do not have access to the proposed detection methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective detection and treatment options for tuberculosis, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promise in developing novel detection methods for tuberculosis, indicating that this approach has the potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Bertozzi, Carolyn — Stanford University
- Study coordinator: Bertozzi, Carolyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.